| Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients HCF Côté, ZL Brumme, KJP Craib, CS Alexander, B Wynhoven, L Ting, ... New England Journal of Medicine 346 (11), 811-820, 2002 | 735 | 2002 |
| Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy PR Harrigan, RS Hogg, WWY Dong, B Yip, B Wynhoven, J Woodward, ... The Journal of infectious diseases 191 (3), 339-347, 2005 | 562 | 2005 |
| Adaptation of HIV-1 to human leukocyte antigen class I Y Kawashima, K Pfafferott, J Frater, P Matthews, R Payne, M Addo, ... Nature 458 (7238), 641-645, 2009 | 561 | 2009 |
| Influence of HLA-C expression level on HIV control R Apps, Y Qi, JM Carlson, H Chen, X Gao, R Thomas, Y Yuki, ... Science 340 (6128), 87-91, 2013 | 412 | 2013 |
| Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection MR Henn, CL Boutwell, P Charlebois, NJ Lennon, KA Power, ... PLoS pathogens 8 (3), e1002529, 2012 | 397 | 2012 |
| Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals ZL Brumme, J Goodrich, HB Mayer, CJ Brumme, BM Henrick, ... The Journal of infectious diseases 192 (3), 466-474, 2005 | 353 | 2005 |
| HLA-B57/B* 5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T … T Miura, MA Brockman, A Schneidewind, M Lobritz, F Pereyra, A Rathod, ... Journal of virology 83 (6), 2743-2755, 2009 | 345 | 2009 |
| Antigen Load and Viral Sequence Diversification Determine the Functional Profile of HIV-1–Specific CD8+ T Cells H Streeck, ZL Brumme, M Anastario, KW Cohen, JS Jolin, A Meier, ... PLoS medicine 5 (5), e100, 2008 | 317 | 2008 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 292 | 2005 |
| Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ... PLoS medicine 12 (4), e1001810, 2015 | 285 | 2015 |
| TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection H Chen, ZM Ndhlovu, D Liu, LC Porter, JW Fang, S Darko, MA Brockman, ... Nature immunology 13 (7), 691-700, 2012 | 276 | 2012 |
| Operationalizing the One Health approach: the global governance challenges K Lee, ZL Brumme Health policy and planning 28 (7), 778-785, 2013 | 230 | 2013 |
| HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins ZL Brumme, M John, JM Carlson, CJ Brumme, D Chan, MA Brockman, ... PloS one 4 (8), e6687, 2009 | 210 | 2009 |
| Marked epitope-and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early … ZL Brumme, CJ Brumme, J Carlson, H Streeck, M John, Q Eichbaum, ... Journal of virology 82 (18), 9216-9227, 2008 | 207 | 2008 |
| Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1 ZL Brumme, CJ Brumme, D Heckerman, BT Korber, M Daniels, J Carlson, ... PLoS pathogens 3 (7), e94, 2007 | 206 | 2007 |
| Definition of the viral targets of protective HIV-1-specific T cell responses B Mothe, A Llano, J Ibarrondo, M Daniels, C Miranda, J Zamarreño, ... Journal of translational medicine 9, 1-20, 2011 | 192 | 2011 |
| Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir HCF Côté, ZL Brumme, PR Harrigan Journal of virology 75 (2), 589-594, 2001 | 175 | 2001 |
| Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag JM Carlson, ZL Brumme, CM Rousseau, CJ Brumme, P Matthews, ... PLoS computational biology 4 (11), e1000225, 2008 | 170 | 2008 |
| HLA-Associated Alterations in Replication Capacity of Chimeric NL4-3 Viruses Carrying gag-protease from Elite Controllers of Human Immunodeficiency Virus Type 1 T Miura, MA Brockman, ZL Brumme, CJ Brumme, F Pereyra, A Trocha, ... Journal of virology 83 (1), 140-149, 2009 | 157 | 2009 |
| Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes T Miura, MA Brockman, CJ Brumme, ZL Brumme, JM Carlson, F Pereyra, ... Journal of virology 82 (17), 8422-8430, 2008 | 156 | 2008 |
